Mohawk Industries (MHK) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
27 Feb, 2026Executive summary
Q4 2025 net sales reached $2.7 billion, up 2.4% as reported, with adjusted EPS at $2.00 and adjusted operating income at $152 million; performance outpaced most markets, especially in commercial segments.
Full-year 2025 sales were $10.8 billion, flat year-over-year; adjusted EPS was $8.96, down 7.5%; adjusted net earnings were $559 million.
Free cash flow for 2025 was $620–621 million, with $149–150 million spent on share repurchases.
Housing turnover and consumer confidence remained weak due to affordability, inflation, and geopolitical tensions, impacting discretionary spending.
U.S. accounted for 55% of 2025 sales, Europe 30%, and other geographies 15%.
Financial highlights
Q4 2025 adjusted gross profit margin was 24.3%; adjusted operating margin was 5.6%.
Q4 2025 adjusted EBITDA was $301 million; trailing twelve months adjusted EBITDA was $1.3 billion.
Net debt at year-end 2025 was $1.17 billion; leverage at 0.9x adjusted EBITDA.
Net cash from operating activities for 2025 was $1.06 billion; capital expenditures were $435 million.
Annual net sales for 2025 were $10.8 billion, down 0.5% year-over-year; adjusted EBITDA margin was 12.1%.
Outlook and guidance
Q1 2026 expected to be seasonally slow, with adjusted EPS guidance of $1.75–$1.85, excluding restructuring or one-time charges.
2026 sales and earnings are expected to improve, contingent on economic and housing market recovery, with growth driven by sales initiatives, product innovation, and operational improvements.
Full-year 2026 CapEx planned at $480 million, focused on product innovation, cost reduction, and maintenance.
Recent restructuring initiatives expected to generate $60–70 million in savings in 2026.
Corporate expenses for 2026 estimated at $52–$55 million.
Latest events from Mohawk Industries
- Q2 adjusted EPS up 9% as cost actions and cash flow offset weak sales and market pressures.MHK
Q2 20242 Feb 2026 - Q3 2024 adjusted EPS up 7% to $2.90; 2025 recovery expected as rates decline.MHK
Q3 202418 Jan 2026 - Q1 2025 sales fell 5.7% to $2.53B; adjusted EPS $1.52; tariffs add $50M in costs.MHK
Q1 202525 Dec 2025 - Adjusted EPS steady at $1.95 as cost actions offset weak demand; $285M savings targeted.MHK
Q4 20249 Dec 2025 - Proxy covers director elections, auditor ratification, executive pay, and ESG priorities.MHK
Proxy Filing1 Dec 2025 - Q3 2025 sales up 1.4% to $2.8B, with $110M in savings and ongoing cost actions amid soft demand.MHK
Q3 202524 Oct 2025 - Flat Q2 2025 sales, margin pressure, and a $500M buyback amid ongoing cost and tariff risks.MHK
Q2 202525 Jul 2025